Steward Partners Investment Advisory, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 605 shares of ARWR stock, worth $9,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
605
Previous 305
98.36%
Holding current value
$9,111
Previous $5,000
120.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$236 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$183 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$167 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$90.6 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$78.8 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.59B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...